ACTA1 and cancer: Furthermore, these tumors did not show a reduction in the levels of phospho-SMAD3, a representative downstream mediator of TGFβ signaling, and cancer-associated fibroblast (CAF) marker αSMA (Supplementary Fig. 6c, d).